Tissue Regeneration Technologies, Inc.
United StatesFDA applicant, unverified
- Devices
- 5
What Tissue Regeneration Technologies, Inc. makes
Tissue Regeneration Technologies, Inc. manufactures the LITHOGOLD device, which is an extracorporeal shock wave therapy system.
The company is based in the United States, and its device is classified as Class II and listed in the FDA 510(k) registry.
Catalogue
OrthoGold 100 Ref K210451
Regimes: 510(k) Registry: 510(k)OrthoGold Ref K191961
Regimes: 510(k) Registry: 510(k)OrthoGold 100 Ref K200926
Regimes: 510(k) Registry: 510(k)OrthoGold 100 Ref K182682
Regimes: 510(k) Registry: 510(k)Lithogold Ref K062081
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Tissue Regeneration Technologies, Inc. have in the registry?
The registry currently lists 5 devices for Tissue Regeneration Technologies, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Tissue Regeneration Technologies, Inc.'s devices?
Among its 5 most recently registered devices, Tissue Regeneration Technologies, Inc. has devices listed in FDA 510(k) (5 devices).
What risk classes do Tissue Regeneration Technologies, Inc.'s devices fall under?
Among its 5 most recently registered devices, the classes recorded for Tissue Regeneration Technologies, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Tissue Regeneration Technologies, Inc. in the registry?
The most recently registered devices listed for Tissue Regeneration Technologies, Inc. include OrthoGold 100, OrthoGold and LITHOGOLD.